Inst. Holders
1 funds
EXAS
EXACT SCIENCES CORP
—
12-mo target$106.30 (+1.3%)
High Impact Filing (7/10)50 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on EXAS right now — valuation, ownership and activity at a glance.
Inst. Value
$1.8K
Inst. Activity
0 buys / 50 sells
Social Sentiment
67° Warm
SEC Reports
4
Congressional
1 trades
Price chart
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 4, 2026 earnings_calendar
Jul 31, 2026 SEC EXAS Q2 2026 Earnings After Market Close — 2026-08-04
The U.S. District Court for the Western District of Pennsylvania partially granted and partially denied Exact Sciences'
COURT-RULING — Impact 2/10
Jul 29, 2026 Event
Jun 12, 2026 SEC SULLIVAN v. EXACT SCIENCES CORPORATION
Court ruling (pawd) — Docket: 3:22-cv-00116
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M), and Soros (+$16.3M)
INST-CLUSTER — Impact 5/10
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligations, citing fewer t
15-12G — Impact 7/10
Mar 31, 2026 Inst.
WEALTH ENHANCEMENT ADVISORY SERVICES, — NEAR_EXIT
11,481 shares ($1.2M)
Mar 31, 2026 Inst.
VAN ECK ASSOCIATES CORP — NEAR_EXIT
20,917 shares ($2.2K)
Mar 24, 2026 Congress
Kevin Hern sell
$1,001 - $15,000 — House
Analyst ratings buy % -17.6%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jan 20, 2026 | Mizuho | DOWNGRADE | Neutral | 52% |
| Jan 5, 2026 | Evercore ISI Group | DOWNGRADE | In-Line | 59% |
| Nov 28, 2025 | Stifel | DOWNGRADE | Hold | 54% |
| Nov 25, 2025 | Canaccord Genuity | DOWNGRADE | Hold | 47% |
| Nov 24, 2025 | Benchmark | DOWNGRADE | Hold | 54% |
| Nov 24, 2025 | Jefferies | DOWNGRADE | Hold | 53% |
| Nov 21, 2025 | Wells Fargo | DOWNGRADE | Equal-Weight | 54% |
| Nov 21, 2025 | William Blair | DOWNGRADE | Market Perform | 51% |
| Nov 21, 2025 | Guggenheim | DOWNGRADE | Neutral | 52% |
| Nov 21, 2025 | Barclays | DOWNGRADE | Equal-Weight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Jun 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| May 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Apr 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Mar 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Feb 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Jan 1, 2026 | 2 | 8 | 19 | 0 | 0 | 34% |
Price targets
Where 10 covering analysts think EXAS trades over the next 12 months.
$106.30 +1.3% upside Hold
Current$104.91 Low$105.00 Median$105.00 High$118.00 10 analysts
$105.00$118.00
Analyst rating Hold· 2.9/5 as of May 19, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
67°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 1 bearish, 1 mixed, 1 neutral · avg impact 5.3/10.
NEUTRALCOURT-RULING2/10
The U.S. District Court for the Western District of Pennsylvania partially granted and partially den
Jul 31, 2026
BULLISHINST-CLUSTER5/10
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M),
Jun 12, 2026
BEARISH15-12G7/10
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligat
Apr 2, 2026
MIXEDINST-CLUSTER7/10
Three major institutions—Morgan Stanley, Norges Bank, and RenTech—collectively added $732.4M in new
Feb 28, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 4, 2026
earnings_calendar
EXAS Q2 2026 Earnings After Market Close — 2026-08-04
Jul 29, 2026
Enforcement
SULLIVAN v. EXACT SCIENCES CORPORATION
Court ruling (pawd) — Docket: 3:22-cv-00116
Apr 29, 2026
earnings_calendar
EXAS Q1 2026 Earnings After Market Close — 2026-04-29
Mar 23, 2026
short_interest
FTD: EXAS — 6,494 shares ($0.7M) failed to deliver
Settlement: 20260323, Price: $104.91, FTD Value: $681,285.54, EXACT SCIENCES CORPORATION
Mar 16, 2026
dark_pool
Dark Pool: EXAS — 4.2M shares, 40,329 trades
Week starting 2026-03-16. Total ATS volume: 4,172,137 shares across 40,329 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Next Q | $0.28 | $0.28–$0.28 | 180.3% | -7.7% | 3↑ 0↓ | $0.9B | 1 |
| Current Q | $0.05 | $0.05–$0.05 | 114.0% | +114.3% | 1↑ 1↓ | $0.8B | 1 |
| Next FY | $1.90 | $1.90–$1.90 | 108.8% | +1.1% | 1↑ 3↓ | $4.1B | 1 |
| Current FY | $0.91 | $0.91–$0.91 | 1200.0% | -19.8% | 3↑ 0↓ | $3.7B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.050 | — |
| 7d ago | $0.023 | +0.027 |
| 30d ago | $0.023 | +0.027 |
| 60d ago | $0.103 | -0.053 |
| 90d ago | $0.103 | -0.053 |
Institutional ownership
Which big funds own EXAS (from quarterly 13F filings) and who is adding or trimming.
1 institutional holders with $1.8K total value (1 shares) as of 2026-Q2. Top holders: HUNTINGTON.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1.8K | 100.0% | NEAR_EXIT -96.6% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | NEAR_EXIT | 93,066 | 11,481 | -87.7% | $1.2M |
| VAN ECK ASSOCIATES CORP | NEAR_EXIT | 109,126 | 20,917 | -80.8% | $2.2K |
| HUNTINGTON NATIONAL BANK | NEAR_EXIT | 29 | 1 | -96.6% | $1.9K |
| HBK INVESTMENTS L P | EXIT | 7,646,637 | 0 | -100.0% | $0.00 |
| Schonfeld Strategic Advisors LLC | EXIT | 592,847 | 0 | -100.0% | $0.00 |
| Caption Management, LLC | EXIT | 170,679 | 0 | -100.0% | $0.00 |
| Candriam S.C.A. | EXIT | 166,157 | 0 | -100.0% | $0.00 |
| IEQ CAPITAL, LLC | EXIT | 303,816 | 0 | -100.0% | $0.00 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | EXIT | 157,460 | 0 | -100.0% | $0.00 |
| Man Group plc | EXIT | 965,093 | 0 | -100.0% | $0.00 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
14 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Conroy Kevin T | President and CEO | AWARD | 119,312 | — | — |
| Mar 23, 2026 | Conroy Kevin T | President and CEO | D | 18,143 | — | — |
| Mar 23, 2026 | Condella Sarah | EVP, Human Resources | D | 191,891 | — | — |
| Mar 23, 2026 | Petrovic Shacey | Director | D | 16,406 | — | — |
| Mar 23, 2026 | Trigg Leslie | Director | D | 3,244 | — | — |
| Mar 23, 2026 | Barber Michael J | Director | D | 7,422 | — | — |
| Mar 23, 2026 | Clancy Paul J | Director | D | 20,640 | — | — |
| Mar 23, 2026 | Barber Michael J | Director | D | 7,738 | — | — |
| Mar 23, 2026 | Popovits Kimberly J | Director | D | 6,725 | — | — |
| Mar 23, 2026 | Conroy Kevin T | President and CEO | D | 235,388 | — | — |
Congressional trades
EXAS trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Kevin Hern | R | HOUSE | SELL | $1,001 - $15,000 | Exact Sciences Corporation | Apr 6, 2026(14d) |
All EXAS filing & press-release reports (4)
- COURT-RULING reportJul 31, 2026
- INST-CLUSTER reportJun 12, 2026
- 15-12G reportApr 2, 2026
- INST-CLUSTER reportFeb 28, 2026